For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

Published in the Journal of the American Medical Association (JAMA), the letter says that the dismissal of the advisors and the appointment of eight new ACIP members two days later, along with ...

Kraft Heinz announced on Tuesday that it would be removing artificial food dyes from its products within the next two ...

Republican lawmakers in Ohio are planning on introducing a bill on Wednesday that would ban almost all abortions and ...